We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Dementia Associated With Altered Immune System

News

Recent research has revealed increased inflammatory activity in some patients with frontotemporal dementia.

READ MORE

Hormone Therapy Battles Cognitive Decline

News

A new study has identified benefits of extended estrogen exposure and longer-term hormone therapy in combating cognitive decline

READ MORE

Harmful Gene Interactions Trigger Rare Form of GI Tumor

News

The "breakdown" of the normal 3D shape of DNA enables harmful interactions to form between genes in a rare type of gastrointestinal stromal tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE